Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium

Schizophr Bull. 2024 Jan 1;50(1):5-8. doi: 10.1093/schbul/sbad112.
No abstract available

MeSH terms

  • Antipsychotic Agents* / pharmacology
  • Antipsychotic Agents* / therapeutic use
  • Drug Tapering
  • Humans
  • Mental Disorders* / drug therapy
  • Professional Practice Gaps

Substances

  • Antipsychotic Agents